The company will initially supply prototypes to diverse customers to evaluate in purification processes for producing gene therapy drugs with a view to swift commercialization
New research labs and process development services to enable next generation therapeutics
At 24 months, data from the Phase 1 exPDite trial continue to show a favorable safety profile in all 12 participants in the trial’s high and low dose cohorts
The robotic surgery program has continually pushed the boundaries of medical technology
Bemdaneprocel is the most clinically advanced investigational cell therapy in the U.S. for treating patients living with Parkinson’s disease
The new facility will accelerate the biotech and pharmaceutical industry's development by manufacturing vaccines, cell and gene therapies, and protein-based therapies
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
This advanced technology is specifically tailored for individuals with high power prescriptions, aiming to free the 18-35 age group from the reliance on eyeglasses
Subscribe To Our Newsletter & Stay Updated
